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Abstract
Background: The various autonomic control systems lead to characteristic changes in heart rate (HR) and blood
pressure (BP) during acute hemorrhage. However, cardiovascular autonomic neuropathy due to diabetes mellitus
may interfere with the normal compensation for hemorrhage.
Materials and methods: A controlled graded bleeding (6 - 36% loss of estimated total blood volume: ETBV) was
performed in streptozotocin-induced diabetic rats (STZ rats) under a conscious state. Hemodynamic and autonomic
responses to acute hemorrhage were examined using analysis of BP-HR variability. The effects of dextran treatment
after hemorrhage were also examined.
Results: A significant reduction in mean arterial pressure began at 12% ETBV loss in STZ rats and 18% in the
control rats, respectively. When blood loss reached 18% of TEBV, the decrease in HR was prominent in STD rats
due to the activation of a parasympathetic drive, as indicated by the increase in high frequency (HF; 0.75~3.0 Hz)
power in HR variability, while in the control rats this response was not observed. The administration of dextran
prevented the activation of the parasympathetic drive in STZ rats during hemorrhaging. In the control rats, the
dextran treatment sustained the initial increase in HR with reduced HF power in HR variability.
Conclusion: STZ rats showed different hemodynamic and autonomic responses to acute hemorrhage from the
control rats. STZ rats were prone to develop bradycardiac hypotension characterized by marked parasympathetic
activation during hemorrhaging. This finding suggests enhancement of the Bezold-Jarisch reflex in STZ rats.
Dextran treatment to maintain a normovolemic hemorrhage state inhibits this reflex.
Introduction
Cardiovascular autonomic neuropathy (CAN) is a major
complication of diabetes mellitus and the most clinically
important form of diabetic neuropathy. CAN is asso-
ciated with abnormalities in heart rate control and vas-
cular dynamics. Clinical manifestations of CAN include
orthostatic hypotension, resting tachycardia, exercise
intolerance, intraoperative cardiovascular liability, and
silent myocardial infarction [1]. Furthermore, it is
known that CAN induces lethal cardiac arrhythmia
from prolongation of the QT interval and can be a
cause of sudden death.
Patients with CAN require close perioperative
anesthesia supervision. Compared with non-diabetic
patients, diabetic patients undergoing general anesthesia
may experience a greater degree of reduction in heart
rate (HR) and blood pressure (BP) during induction of
anesthesia [2]. It has been demonstrated that intraopera-
tive vasopressor support was needed more often in dia-
betic patients with CAN than in those without [3,4].
Acute bleeding is a major factor affecting perioperative
circulatory dynamics. The classical description of the
response to acute hemorrhage involves a sustained
increase in sympathetic activity to maintain arterial BP.
However, recent studies of the effects of acute hemor-
r h a g eh a v ec l e a r l yd e m o n s t r a t e dab i p h a s i ch e m o d y -
namic response [5,6]. During mild hemorrhage, BP is
well maintained by an increase in vascular resistance
and HR. A baroreceptor-mediated sympatho-excitatory
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tral blood volume is critically reduced by more than
30% of ETBV, a second phase develops suddenly. This
phase is characterized by withdrawal of sympathetic
drive and activation of parasympathetic drive. A severe
fall in BP associated with bradycardia develops. Blood
volume and cardiac filling become critically reduced,
which activates the sympatho-inhibitory cardiodepressor
reflex (Bezold-Jarisch (B-J) reflex) [7-9]. This reflex
probably originates in the heart and is triggered by acti-
vation of myocardial mechanoreceptors, which are sti-
mulated by vigorous contractions around a nearly empty
left ventricular cavity. As a result, vagal afferents inhibit
central cardiovascular centers, overrule their baroreflex-
mediated activation, and deactivate the sympathetic ner-
vous system. The B-J reflex is thought to be a protective
response, defending the heart against ischemia during
severe hypovolemia by reducing its workload through
induction of bradycardia, negative inotoropy, and after-
load reduction.
In diabetic patients with CAN, this compensation
mechanism may not work adequately because some evi-
dence suggests that both the sympathetic and parasympa-
thetic nervous system are impaired in patients with
insulin-dependent diabetes mellitus [1,10,11]. However, lit-
tle is known about autonomic and hemodynamic responses
to acute hemorrhage in diabetic patients with CAN.
In the present study, we explored hemodynamic and
autonomic responses to acute hemorrhage in streptozo-
tocin-induced diabetic rats (STZ rats). The present
study was designed to minimize handling-induced stress
and well-known cardiovascular and autonomic effects
elicited by commonly used anesthetic agents.
Cardiovascular autonomic function was assessed by
using spectral analysis of BP and HR variability. Using
this method, we could evaluate autonomic function with
minimum intervention throughout the study. Data ana-
lysis was performed with wavelet transformation because
this method has a high time-resolving power. We evalu-
ated efferent sympathetic activity using the low fre-
quency (LF) component of systolic blood pressure (SBP)
variability [12]. The LF component of SBP (SBP-LF)
increases in conditions associated with various sympa-
thetic activations [13-15]. Furthermore, SBP-LF is posi-
tively correlated with muscular sympathetic nerve
activity, providing more direct support for the concept
of using changes in the SBP-LF as a marker of changes
in sympathetic efferent activity in the peripheral vascula-
ture [16]. Therefore, we believe that analyzing SBP-LF
can be used to assess sympathetic activity during acute
hemorrhage. Power-spectral analysis of HR variability is
routinely used as a noninvasive means of quantifying
cardiac autonomic input. The high frequency (HF) peak
represents respiratory sinus arrhythmia and is a reliable
indicator of parasympathetic efferent activity. The ratio
of LF to HF in HR variability was also calculated as an
index of the autonomic nervous system balance [17].
Although the plasma catecholamine concentration is a
useful indice of sympathetic activity, it is not so sensitive
to changes in sympathetic nervous activity, so spectral
analysis of BP and HR variability were used in the pre-
sent study [18,19].
Here, we aimed to investigate the effects of diabetic
CAN on response to acute hemorrhage. To this end, we
studied hemodynamic and autonomic responses to acute
hemorrhage in STZ rats. Using conscious unrestrained
rats and spectral analysis of BP and HR variability
enabled us to the isolate influence of acute hemorrhage.
Materials and methods
The study protocol for animal experiments was
approved by the Institute of Experimental Animal
Sciences, Osaka University Graduate School of Dentis-
try, and carried out in accordance with the National
Institutes of Health Guide for the Care and Use of
Laboratory Animals (NIH Publications No. 80-23),
revised in 1996. All efforts were made to minimize the
number of animals used and their suffering.
Animal preparation
Experiments were performed on male Wistar rats
weighing between 300 and 350 g housed in individual
cages with free access to water and standard rat food.
After an overnight fast (about 12 hours), diabetes was
induced by a single intraperitoneal injection of strepto-
zotocin (STZ; 65 mg/kg). Five days after STZ adminis-
tration, blood was obtained from a tail vein to
determine blood glucose and ketone levels using a
MediSence Precision Xtra™(Abbott Japan CO., LTD).
Only those rats with plasma blood glucose concentra-
t i o n so fm o r et h a n3 0 0m g / d la n dak e t o n eb o d yl e v e l
of more than 0.5 mmol/l were considered diabetic and
included in our study.
Eleven days after STZ administration, the diabetic rats
were surgically prepared with catheters under anesthesia
with intraperitoneal pentobarbital. A polyethylene cathe-
ter was inserted into a femoral artery for arterial pres-
sure measurement and blood withdrawal. Another
catheter was inserted into the left jugular vein for drug
administration. These catheters were tunneled subcuta-
neously to exit from the neck. To prevent catheter
obstruction, heparin-containing saline was injected every
12 hours until the experiment day. Rats were allowed 3
days to recover from surgery. As a control group, rats
without STZ administration received the same operation
(control rats).
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The arterial catheter was connected to a pressure
transducer and a blood pressure waveform was ampli-
fied. The signal passed through an A/D converter
(KPCMCIA-16AI-C, KEITHLEY) at a sampling fre-
quency of 1,000Hz was stored continuously on a perso-
nal computer for later analysis. The mean arterial
pressure (MAP) and SBP were recorded from artifact-
free digitized signals using commercially available
software for rats (Fluclet™, Dainippon Sumitomo Phar-
maceutical Co., Ltd., Osaka, Japan). HR was calculated
from the number of peaks in the pressure waveform.
Data for SBP and HR were analyzed by power spectral
analysis, by which they were automatically separated
into two frequency bands: a low frequency band (LF:
0.25 - 0.75 Hz) and a high frequency band (HF: 0.75 -
3.0 Hz) [12,20].
Experimental protocol
After the baseline recording, the experimental protocol
was started. STZ and control rats were sequentially
assigned to either a hypovolemic group or normovole-
mic group.
In the hypovolemic group, a 1 ml syringe was con-
nected to the femoral arterial catheter. Blood was manu-
ally withdrawn via a syringe from femoral arterial line
for a total volume of 6% of ETBV (about 1.2 ml). ETBV
was calculated using a previously reported equation for
estimating rat blood volume: 0.06 ml/g ×body weight (g)
+ 0.77 [21]. Each rat was bled in six cycles, with each
cycle followed by a 20-minute observation period.
Hemodynamic and autonomic recordings were obtained
5 min (acute phase) and 10 min (plateau phase) after
each controlled hemorrhage.
In the normovolemic group, each rat was given the
same volume of dextran as the blood withdrawal for 15
minutes after each blood withdrawal. This procedure
was repeated 6 times to produce normovolemic hemodi-
lution. Hemodynamic and autonomic recordings were
obtained 5 min (acute phase) and 10 min (plateau
phase) after each dextran infusion.
Arterial blood was analyzed to determine pH, PaCO2,
PaO2, base excess, bicarbonate level and hemoglobin
concentration using Rapid Lob 860 (Siemense) at each
stage of blood removal. The respiratory rate was also
measured by observation.
Baroreflex Sensitivity (BRS)
In an additional group of STZ and control rats, BRS was
explored using the conventional Oxford method [22,23].
After 30 minutes of baseline recording, each rat received
as i n g l ei n t r a v e n o u sb o l u si n jection (0.1 ml) of pheny-
lephrine (0.2 - 2.7 μg/kg) or sodium nitroprusside (0.8 -
27.0 μg/kg) to increase and reduce SBP by 15 - 30
mmHg, respectively. The pressor test was always per-
formed first. Typically, a 30 minute stabilization period
between the pressure and depressor test allowed SBP
and HR to return to the pretest values ± 5%. The maxi-
mal response of SBP to phenylephrine or sodium nitro-
prusside and the corresponding maximal reflex change
in pulse interval were plotted for each drug. BRS was
expressed by the slope of the linear regression calculated
based on the reflex change in the pulse interval to a
given change in SBP.
Statistical analysis
Results are expressed as the mean ± SD throughout the
article. Data analyses were carried out using SPSS for
Windows. Statistical analyses were performed using the
unpaired t-test for comparisons of baseline values
between two groups. ANOVA for repeated measures
followed by Dunnet’st e s tw e r eu s e df o rc o m p a r i s o n so f
g r o u pd i f f e r e n c e s .Apv a l u eo fl e s st h a n0 . 0 5w a sc o n -
sidered statistically significant.
Results
Baseline values in STZ and control rats (Table 1, Figure 1,
2, 3, 4 and 5)
Resting HR, MAP, SBP-LF, HR-HF, HR-LF/HF ratios in
STZ rats were lower than those in control rats. The
blood glucose level increased to 356.5 ± 12.7 mg/dl in
STZ rats. The corresponding value in control rats was
111.1 ± 9.3 mg/dl. The beta hydroxybutyric acid level
was also higher in STZ rats (1.1 ± 0.5 mmol/l) than that
in control rats (0.0 ± 0.0 mmol/l). The hemoglobin con-
centration in STZ rats was slightly lower than that in
control rats. In arterial blood gas analysis, pH, PaCO2,
HCO3
- and base excess in STZ rats were significantly
lower than those in control rats. There was no differ-
ence in the respiratory rate between STZ and control
rats.
BRS was expressed by the slope of the regression line
relating to changes between the pulse interval and SBP.
The gain in the pressor response due to the administra-
tion of phenylephrine was 0.78 ± 0.01 ms/mmHg in
STZ rats and 0.98 ± 0.12 ms/mmHg in control rats.
There was a significant difference between STZ and
control rats. The gain in the depressor response due to
sodium nitroprusside was 0.75 ± 0.01 ms/mmHg in STZ
rats and 0.96 ± 0.10 ms/mmHg in control rats, respec-
tively. This index in STZ rats was also significantly
reduced when compared with control rats.
Hemodynamic and autonomic responses to acute
hemorrhage
A significant decrease in HR was observed in STZ rats
between 18% and 30% TEBV loss following a transient
increase at 6 and 12% ETBV loss. Although control rats
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response disappeared between 18% and 30% EEBV loss.
In STZ rats, a fall in MAP was observed at 12% ETBV
loss and this persisted throughout the subsequent blood
withdrawal. In control rats, MAP did not decrease until
18% of ETBV was withdrawn. Decompensated hypoten-
sion in STZ rats occurred earlier than in control rats.
SBP-LF increased in the acute phase in both rats up to
18% ETBV loss. Although SBP-LF did not show any
changes in either group at 24% ETBV loss, when the
Table 1 Changes in Blood Gas, Hemoglobin, Respiratory Rate in STZ and Control Rats during Acute Hemorrhage
baseline 6% ETBV 12% ETBV 18% ETBV 24% ETBV 30% ETBV 36% ETBV
loss loss loss loss loss loss
Hb
(g/dL)
STZ 12.9 ± 0.6 # 12.8 ± 0.8 11.4 ± 0.3* 10.1 ± 0.5* 9.7 ± 0.6* 9.3 ± 0.9* 8.8 ± 0.8*
Control 14.1 ± 1.2 13.8 ± 0.7 11.6 ± 1.1* 11.6 ± 1.0* 10.2 ± 0.9* 9.5 ± 0.6* 8.9 ± 0.7*
pH STZ 7.36 ± 0.03 # 7.36 ± 0.01 7.37 ± 0.03 7.36 ± 0.03 7.37 ± 0.02 7.36 ± 0.01 7.35 ± 0.02*
Control 7.41 ± 0.04 7.42 ± 0.01 7.41 ± 0.02 7.42 ± 0.02 7.41 ± 0.02 7.41 ± 0.02 7.38 ± 0.01*
PaCO2
(mmHg)
STZ 35.7 ± 0.9 #. 37.2 ± 2.4 34.2 ± 4.2 29.8 ± 1.5* 28.4 ± 1.5* 29.4 ± 1.7* 26.7 ± 2.8*
Control 42.5 ± 4.6 39.0 ± 1.6 34.6 ± 2.6* 33.6 ± 4.4* 30.1 ± 4.4* 26.8 ± 5.4* 21.2 ± 3.9*
HCO3
-
(mmol/L)
STZ 21.6 ± 3.1# 21.4 ± 2.2 19.7 ± 1.6 18.5 ± 0.9* 17.5 ± 2.1* 15.8 ± 2.8* 13.6 ± 3.0*
Control 24.9 ± 2.1 25.1 ± 0.7 22.1 ± 1.3 22.0 ± 1.7 19.4 ± 1.6* 16.5 ± 2.7* 14.9 ± 1.3*
BE
(mEq/L)
STZ -3.4 ± 1.5 # -3.8 ± 2.2 -3.7 ± 1.2 -3.9 ± 2.3 -2.8 ± 1.4 -5.0 ± 1.9* -7.2 ± 1.3*
Control 1.6 ± 1.5 1.1 ± 0.7 -0.4 ± 1.3 -1.2 ± 1.0* -2.9 ± 1.3* -4.3 ± 1.4* -5.3 ± 1.3*
RR
(times/nin)
STZ 84 ± 5 90 ± 5 100 ± 8 122 ± 7* 137 ± 16* 139 ± 20* 144 ± 12*
Control 84 ± 4 86 ± 7 100 ± 6 119 ± 9* 133 ± 18* 141 ± 19* 142 ± 15*
Data are the mean ± SD. STZ rats n = 8, Control rats n = 8
# P < 0.05 STZ rats versus Control rats for baseline values;
* P < 0.05 versus the baseline value
Figure 1 HR responses to acute hemorrhage. Data are the mean ± SD. STZ rats n = 8, Control rats n = 8. # P < 0.05 STZ rats versus Control
rats for baseline values; * P < 0.05 versus the baseline value A: acute phase, P: plateau phase.
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Page 4 of 14Figure 2 MAP responses to acute hemorrhage. Data are the mean ± SD. STZ rats n = 8, Control rats n = 8. # P < 0.05 STZ rats versus Control
rats for baseline values; * P < 0.05 versus the baseline value A: acute phase, P: plateau phase.
Figure 3 SBP-LF responses to acute hemorrhage.D a t aa r et h em e a n±S D .S T Zr a t sn=8 ,C o n t r o lr a t sn=8 .#P<0 . 0 5S T Zr a t sv e r s u s
Control rats for baseline values; * P < 0.05 versus the baseline value A: acute phase, P: plateau phase.
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Page 5 of 14Figure 4 HR-HF responses to acute hemorrhage. Data are the mean ± SD. STZ rats n = 8, Control rats n = 8. # P < 0.05 STZ rats versus
Control rats for baseline values; * P < 0.05 versus the baseline value A: acute phase, P: plateau phase.
Figure 5 HR-LF/HF responses to acute hemorrhage. Data are the mean ± SD. STZ rats n = 8, Control rats n = 8. # P < 0.05 STZ rats versus
Control rats for baseline values; * P < 0.05 versus the baseline value A: acute phase, P: plateau phase.
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SBP-LF increased again in control rats, while it
decreased in STZ rats. HR-HF increased significantly
between 18 and 30% ETBV loss in STZ rats. On the
other hand, in control rats, HR-HF remained unchanged
between 12 and 30% ETBV loss after a transient reduc-
tion in the plateau phase at 6% ETBV loss. Finally, both
rats showed reduced HR-HF at 36% ETBV loss. In STZ
rats, HR-LF/HF increased transiently at 6% ETBV loss
and fell after 18% or more ETBV loss. In control rats,
an elevation in HR-LF/HF was observed in the acute
phase at 6 and 18% ETBV loss and persisted after 30%
or more of ETBV was withdrawn.
Effects on respiratory rate, arterial blood gas analysis and
hemoglobin concentration
The respiratory rate significantly increased in both STZ
and control rats at 18% ETBV loss when compared to
the baseline value. The increase in respiratory rate
speeded up as the blood loss volume increased. There-
fore, PaCO2 significantly decreased in both groups of
rats. Hemoglobin concentration was significantly
reduced when blood loss volume reached 12% or more
of ETBV in both groups of rats; however, there were no
significant differences.
The effects of dextran treatment after hemorrhage
(Tables 2, Figure 6, 7, 8, 9 and 10)
In both groups of rats, hemoglobin concentrations were
significantly reduced after the third blood withdrawal
and dextran treatment as compared with the baseline
values. Therefore, hemodilution occurred after the third
exchange in both rats.
HR increased significantly after the first and second
exchange in STZ rats. In control rats, a significant
increase in HR was sustained after the second exchange.
A reduction in MAP was observed after the third
exchange in both rats. SBP-LF increased transiently after
the first and second exchange and finally decreased in
STZ rats. However, there were no significant changes in
SBP-LF in control rats. STZ rats showed no significant
changes in HR-HF during normovolemic hemodilution,
while control rats showed a significant reduction in HR-
HF. HR-LF/HF increased in control rats between the
first and fifth exchange, while remaining unchanged in
STZ rats.
An increased respiratory rate was observed after the
first exchange in STZ rats and after the second in con-
trol rats.
Discussion
To our knowledge, the present study is the first to eval-
uate the effects of STZ-induced diabetic cardiovascular
autonomic neuropathy during acute hemorrhage using
BP-HR variability analysis. There were two major find-
ings in this study. First, STZ rats showed different
autonomic and hemodynamic responses to acute hemor-
rhage from control rats. During moderate hemorrhage
(18 -30% ETBV loss), the decrease in HR was prominent
in STZ rats due to the activation of parasympathetic
drive, as indicated by the increase in HR-HF, while in
control rats this response was not observed. The second
major finding was that the administration of dextran
prevented the activation of parasympathetic drive in
STZ rats during moderate hemorrhage. Furthermore, in
control rats, dextran treatment sustained the initial
increase in HR with reduced HR-HF throughout the
course of the hemorrhage.
Hemodynamic and autonomic alterations in STZ rats
In experimental studies, administration of STZ is a well-
established method for inducting diabetes in rats. This
model has been commonly used to study the pathogenic
mechanisms of various complications associated with
diabetes, including autonomic dysfunction. In the pre-
sent study, the resting levels of BP and HR were
reduced in STZ rats compared with control rats. These
results were consistent with previous studies [24,25].
The mechanisms underlying the hemodynamic changes
observed in STZ rats are unknown. However, because
impaired BRS and a reduced power spectrum of BP-HR
v a r i a b i l i t yh a v eb e e ns h o w ni nt h es a m ee x p e r i m e n t a l
model [24-28], autonomic alteration is responsible at
least in part for hemodynamic changes in STZ rats. In
addition, the reduced HR may reflect changes in the
electrophysiological properties of the sino-atrial node
[29,30].
There is controversy regarding the alterations in baror-
eflex control of HR in diabetes-induced models. Maeda
et al. reported that the tachycardiac reflex response eli-
cited by a reduction in arterial pressure was attenuated,
while the bradycardiac reflex response to increased arter-
ial pressure was normal, 5 days after STZ administration
[31]. In the present study, we observed attenuation of
both bradycardiac and tachycardiac reflex responses to
blood pressure changes 14 days after STZ administration.
Our results were similar to the results of Carmo et al.
[32], indicating that diabetic rats were associated with
impaired BRS as early as 7 days after STZ administration.
On the other hand, Chang et al. demonstrated that baror-
eflex sensitivity increased 12 weeks after STZ treatment
and decreased 48 weeks later [33]. According to these
results, baroreflex-mediated HR changes appear to be
dependent on the time course of the disease.
Responses to blood withdrawal in STZ rats
Av a r i e t yo fm e t h o d sh a v eb e e nu s e dt oi n d u c eah y p o -
volemic state in previous experiments. They include
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[34,35], bleeding to a fixed arterial blood pressure [36],
a fixed volume of withdrawal [37], and a lower body
negative pressure [38]. The method used to induce
hypovolemia can have a huge impact on hemodynamic
and autonomic responses. Even if the total volume of
blood loss is the same, different results may be obtained
depending on the method of blood withdrawal. In the
present study, a controlled graded bleeding was per-
formed with 20-minute intervals between two
Table 2 Changes in Blood Gas, Hemoglobin, Respiratory Rate in STZ and Control rats during Normovolemic
Hemodilution
baseline 1st 2nd 3nd 4th 5th 6th
exchange exchange exchange exchange exchange exchange
Hb
(g/dL)
STZ 13.4 ± 1.2# 12.1 ± 0.2 11.6 ± 0.4 10.2 ± 1.2* 9.2 ± 0.1* 9.2 ± 0.5* 8.4 ± 0.1
Control 13.6 ± 1.2 12.8 ± 0.5 11.8 ± 1.2 10.2 ± 0.3* 9.5 ± 1.2* 9.0 ± 0.8* 8.2 ± 0.4*
pH STZ 7.36 ± 0.03# 7.35 ± 0.03 7.37 ± 0.03 7.37 ± 0.01 7.37 ± 0.03 7.35 ± 0.02 7.35 ± 0.01
Control 7.44 ± 0.02 7.44 ± 0.03 7.43 ± 0.03 7.42 ± 0.01 7.43 ± 0.01 7.42 ± 0.01 7.39 ± 0.02*
PaCO2
(mmHg)
STZ 37.4 ± 5.4# 37.0 ± 4.1 33.7 ± 5.0 30.5 ± 3.3* 28.4 ± 2.1* 30.0 ± 2.1* 26.6 ± 2.5*
Control 41.4 ± 3.4 35.9 ± 2.1 30.8 ± 2.4* 31.5 ± 2.7* 29.1 ± 0.9* 27.0 ± 1.8* 25.9 ± 2.8*
HCO3
-
(mmol/L)
STZ 22.5 ± 1.8# 21.7 ± 0.5 19.8 ± 1.3 18.3 ± 1.2* 18.0 ± 0.8* 16.6 ± 0.8* 13.6 ± 3.0*
Control 21.1 ± 1.6 19.81 ± 1.8 19.3 ± 1.0 19.4 ± 1.5 20.0 ± 0.7 19.6 ± 1.7 19.9 ± +1.3
BE’
(mEq/L)
STZ -4.1 ± 1.0# -4.3 ± 0.8 -4.5 ± 1.5 -4.6 ± 1.2 -4.8 ± 1.8 -6.0 ± 1.5* -6.9 ± 1.2*
Control 0.8 ± 0.4 -0.8 ± 2.5 -2.3 ± 2.0* -2.2 ± 2.0* -2.4. ± 1.7* -2.3 ± 2.6* -1.3 ± 2.4*
RR
(times/nin)
STZ 85 ± 2 107 ± 15* 118 ± 16* 129 ± 10* 143 ± 14* 140 ± 6* 142 ± 11*
Control 83 ± 5 88 ± 6 111 ± 8* 118 ± 7* 110 ± 11* 108 ± 11* 116 ± 19*
Data are the mean ± SD. STZ rats n = 8, Control rats n = 8
# P < 0.05 STZ rats versus Control rats for baseline values;
* P < 0.05 versus the baseline value
Figure 6 The effects of dextran treatment to HR after hemorrhage. Data are the mean ± SD. STZ rats n = 8, Control rats n = 8. # P < 0.05
STZ rats versus Control rats for baseline values; * P < 0.05 versus the baseline Value A: acute phase, P: plateau phase.
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Page 8 of 14Figure 7 The effects of dextran treatment to MAP after hemorrhage. Data are the mean ± SD. STZ rats n = 8, Control rats n = 8. # P < 0.05
STZ rats versus Control rats for baseline values; * P < 0.05 versus the baseline Value A: acute phase, P: plateau phase.
Figure 8 The effects of dextran treatment to SBP-LF after hemorrhage. Data are the mean ± SD. STZ rats n = 8, Control rats n = 8. # P <
0.05 STZ rats versus Control rats for baseline values; * P < 0.05 versus the baseline Value A: acute phase, P: plateau phase
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Page 9 of 14Figure 9 The effects of dextran treatment to HR-HF after hemorrhage. Data are the mean ± SD. STZ rats n = 8, Control rats n = 8. # P <
0.05 STZ rats versus Control rats for baseline values; * P < 0.05 versus the baseline Value A: acute phase, P: plateau phase.
Figure 10 The effects of dextran treatment to HR-LF/HF after hemorrhage. Data are the mean ± SD. STZ rats n = 8, Control rats n = 8. # P
< 0.05 STZ rats versus Control rats for baseline values; * P < 0.05 versus the baseline Value A: acute phase, P: plateau phase.
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sure the autonomic and hemodynamic response to each
volume of blood loss. BP-HR variability measured in the
plateau phase (10 minutes after withdrawal) reflects the
steady state condition after each blood loss, leaving
ample time for circulatory compensation.
During mild blood loss (6-12% ETBV loss), an
increase in HR was observed in control rats. This
response was associated with a transient reduction in
parasympathetic drive and activation of sympathetic
drive, as indicated by changes in HR-HF power and in
HR-LF/HF and SBP-LF power, respectively. As blood
loss approached a moderate level (18-30% ETBV of
loss), the initial increase in HR disappeared and a signif-
icant reduction in MAP was noted. However, BP-HR
variability did not show any marked changes in this
phase. As the hemorrhage progressed further (more
than 30% ETBV loss), a marked reduction in MAP
developed. In the present study, control rats did not
show the sympatho-inhibitory phase of acute hemor-
rhage characterized by decreased HR associated with
elevated parasympathetic drive to the heart. This inhibi-
tory response is mediated by the B-J reflex. Baujard et
al. showed similar results to ours when using a con-
trolled graded hemorrhage [39]. Porter et al. demon-
s t r a t e dt h a th e m o r r h a g ea tas l o wr a t e( 2 0m l / k g / 4 0
min) did not cause elevation in HR-HF [40]. Conversely,
hemorrhage at an intermediate or fast rate induced a
decrease in HR associated with a significant increase in
HF power [41]. These results suggest that the rate of
hemorrhage has an important impact on autonomic reg-
ulation. Because the method of blood loss used in the
present study may have been equivalent to a slow rate
hemorrhage, the sympatho-inhibitory phase of acute
hemorrhage was not manifested in control rats. Kawase
et al. reported that massive hemorrhage of MAP of 50
mmHg caused two types of response in anesthetized
dogs: bradycardia followed by tachycardia and continu-
ous tachycardia [42]. The HR response to hemorrhage
m a ya l s ob ed e p e n d e n to nt h ea n e s t h e t i cc o n d i t i o no r
species, as well as the rate of hemorrhage.
On the other hand, STZ rats showed significant brady-
cardia associated with the activation of parasympathetic
drive and reduction in sympathetic drive indicated by
HR variability during moderate hemorrhage, despite the
same rate of blood loss as control rats. This different
response to hemorrhage between STZ and control rats
suggests autonomic alteration induced by diabetic neu-
ropathy. The enhancement of the B-J reflex in STZ rats
may reflect the autonomic disterbance. The B-J reflex,
as well as the arterial baroreflex and cardiopulmonary
reflex, constitute a short-term regulatory system
for maintaining cardiovascular stability. The B-J reflex
is elicited by the stimulation of left ventricular
mechanoreceptors and its signal reaches the central
autonomic network via unmyelinated vagal afferent
fibers. Although the B-J reflex has a common afferent
pathway with the aortic baroreflex, the signals from left
ventricular mechanoreceptors connect to a different site
of the brainstem from that of the arterial baroreceptor
[43]. The activation of the brainstem by the B-J reflex
induces an increase in parasympathetic tone to the heart
and the withdrawal of sympathetic nervous activity. Pre-
vious studies indicated that the B-J reflex blunted the
arterial baroreflex due to interference with the barore-
flex signal transduction in the brainstem [44].
Impairment of baroreflex function due to diabetes has
been reported [31-33]. Although the exact site of the
defect in the reflex arch has not been determined, it
could involve sensory baroreceptor endings, the afferent
pathway, connections within the central autonomic net-
work, the efferent component of the reflex pathway, or
altered muscarinic receptors to acetylcholine in the
heart. The present study showed a reduction in the HR
response to blood pressure changes due to the adminis-
tration of phenylephrine or nitroprusside in STZ rats.
However, Dall’Ago et al. demonstrated that the brady-
cardia elicited by electrical stimulation of vagal efferents
induced a greater HR response in diabetic rats com-
pared to controls [45]. They also observed greater bra-
dycardia in response to methacholine in diabetic rats.
Homma et al. studied HR and BP responses to the sti-
mulation of peripheral cut ends of cervical sympathetic
and vagus nerves in diabetic rats and showed that the
HR response was exaggerated and that the BP response
was disturbed in diabetic rats [46]. Furthermore, the
effects of diabetes on the central nervous system are
minimal [47] and diabetic autonomic neuropathy pri-
marily involves the peripheral autonomic nerve. These
findings suggest that the efferent pathway of the barore-
flex is not responsible for the reduced BRS in diabetic
rats.
A reduction in arterial BP and stretching of the car-
diac wall due to massive blood loss reduces the dis-
charge from the arterial baroreceptor and increases the
discharge from the left ventricular mechanoreceptor,
respectively. Although deactivation of the arterial recep-
tor and activation of the mechanoreceptor elicit the
opposite effects on sympathetic nerves and the parasym-
pathetic nervous system, the signals from these recep-
tors are modulated through the central autonomic
network and then the final reflex response develops in
the cardiovascular system. Diabetes impairs the arterial
baroreflex, but not the B-J reflex, according to the
results of the present study. Not all the circulatory
reflexes are impaired equally by diabetes. This finding is
supported by the fact that the impairments in vascular
reactivity to vasoconstrictors due to diabetes vary greatly
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Because the afferent pathway of the arterial baroreflex
seems to be easily influenced by diabetic neuropathy,
the hemodynamic response to the B-J reflex may be
enhanced and consequently, hypotension with bradycar-
dia is manifested in STZ rats.
The B-J reflex has a beneficial effect on the circulatory
system under normal circumstances. Kawase et al.
reported that massive hemorrhage caused two types of
HR response: bradycardia and tachycardia, in anesthe-
tized dogs, and that tachycardiac dogs may have a worse
outcome than bradycardiac dogs [42]. Batchinsky et al.
also showed that a characteristic change in HR variabil-
ity was sympathetic withdrawal due to the B-J reflex in
all surviving subjects after severe hemorrhage [51]. On
the other hand, Barnas et al. demonstrated that activa-
tion of the B-J reflex was involved in severe sympto-
matic hypotension accompanied by bradycardia during
dialysis and that half of the patients who were prone to
dialysis hypotension had a history of diabetes [52]. This
finding suggests that diabetic neuropathy is involved in
enhancement of the B-J reflex. The cardiodepressor
response due to the enhanced B-J reflex may cause
autonomic disturbance in patients with diabetic auto-
nomic neuropathy. Excess activation of the B-J reflex
may lead to severe bradycardiac hypotension, placing
the patient’s life at risk.
The effects of dextan treatment
In STZ rats, the administration of dextran after blood
withdrawal prevented the activation of parasympa-
thetic drive, as indicated by an increased HR-HF. As
a result, bradycardiac hypotension did not develop in
STZ rats. Maintaining cardiac filling with the admin-
istration of dextran inhibited the B-J reflex. The
autonomic response to dextran treatment in control
rats was characterized by reduced parasympathetic
activity and sympathetic predominance. Therefore,
the initial increase in HR was sustained and a reduc-
tion in MAP did not occur until the third hemodilu-
tion. Tanaka et al. reported that arterial baroreflex
control of HR was not altered during profound acute
normovolemic hemodilution to a hemoglobin concen-
tration of 4-5 g/dl using a phenylephrine pressor and
nitroprusside depressor test in pentobarbital-anesthe-
tized dogs [53].
Limitations
There are several limitations to this study. First, there is
a discrepancy in the autonomic condition between STZ-
induced diabetic rats and human diabetic patients. The
results of the present study demonstrated that STZ-
induced diabetes was associated with bradycardia. Our
results are in agreement with the data from other
laboratories [24-28]. On the other hand, the majority of
human clinical studies reported tachycardia. Many
investigators believe that the decline in parasympathetic
function precedes the impairment in sympathetic ner-
vous control in diabetic patients [54,55].
Observed differences between STZ-induced diabetic
rats and patients in clinical situations may result from
species variation or from differences inherent in patho-
genic mechanisms. The induction of diabetes in the rat
results from a single insult to pancreatic beta-cells and
immediate and sustained hyperglycemia develops. On
the other hand, in humans the cause and time of onset
of diabetes are usually unknown and the time course of
the rise in blood glucose less well defined.
Second, the change in respiration may have a pro-
found impact on HR variability parameters. In fact, the
HR-HF power increases as tidal volume increases, inde-
pendent of changes in parasympathetic drive [56,57].
Also, an increase in the respiratory rate could reduce
the HR-HF power [58,59]. In the present study, we mea-
sured only the respiratory rate, but not tidal volume.
Therefore, it is impossible to precisely evaluate the
effects of respiratory control on HR variability. However,
the reduction in HR-HF was not observed in control
rats until 36% of ETBV was withdrawn, despite a consis-
tent increase in respiratory rate after hemorrhage. In
addition, STZ rats showed a decrease in HR-HF during
severe hemorrhage despite an increase in the respiratory
rate. These findings suggest that the difference in HF
power observed during the hemorrhage reflected
increases in parasympathetic drive, rather than changes
in respiratory control induced by hemorrhage. It is
impossible to explain the changes in HR-HF observed in
t h ep r e s e n ts t u d yo n l yo nt h eb a s i so ft h ec h a n g ei n
respiratory control.
Conclusions
In summary, our study demonstrated that rats with dia-
betic neuropathy were sensitive to developing bradycar-
diac hypotension during acute hemorrhage. The
autonomic responses were characterized by marked
parasympathetic activation. These findings suggest
enhancement of the B-J reflex in diabetic rats. On the
other hand, dextran treatment inhibited the B-J reflex.
The mechanisms for an enhanced B-J reflex in diabetic
rats are unknown and future studies are needed to bet-
ter identify them.
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